App-based interstage monitoring in children with congenital heart defects

App-based interstage monitoring in children with congenital heart defects - EVIE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024209

Enrollment

Registered

2021-03-01

Start date

2021-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q23.4 Q22.6

Interventions

Group 1: The study has only one arm, in which the additional use of the application "Evie by DHZB" in combination with the regular communication mode during the interstage monitoring phase is investig

Eligibility

Sex/Gender

All

Age

0 Years to 2 Years

Inclusion criteria

Inclusion criteria: single ventricle defect; surgical treatment with (modified) Norwood (stage I) procedure; indication for interstage monitoring

Exclusion criteria

Exclusion criteria: language barrier, missing device for installation of application

Design outcomes

Primary

Measure	Time frame
Mortality	—

Secondary

Measure	Time frame
Improvement of compliance, reduction in number of hospital admissions, correlation with ability to thrive, optimization of congestive heart failure therapy, patient-reported outcomes	—

Countries

Germany

Contacts

Public ContactLisa-Maria Rosenthal

Deutsches Herzzentrum Berlin Abteilung für angeborene Herzfehler/Kinderkardiologie

rosenthal@dhzb.de030-45932800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026